Augenheilkunde, Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes, Homburg (Saar), Germany.
Klin Monbl Augenheilkd. 2022 Nov;239(11):1361-1368. doi: 10.1055/a-1396-4787. Epub 2021 Apr 14.
To report the indications and outcomes of penetrating keratoplasties with a graft diameter > 8.5 mm in severe corneal diseases at the Department of Ophthalmology at Saarland University Medical Centre.
Retrospective (6 years), descriptive, and observational.
Thirty-five large-diameter penetrating keratoplasties (LDPKPs) in 27 patients (mean age, 62 ± 22 years) were performed from March 2010 to December 2016. The indication for surgery, number of previous corneal transplantations, best-corrected visual acuity (BCVA) before surgery, intraocular pressure, graft status, and BCVA at last follow-up were recorded.
Infectious keratitis represented 83% of the indications (of those, 45% fungal). The mean corneal graft diameter was 10.8 ± 1.7 (min 8.75, max 15.0) mm. Twenty-three eyes (65% absolute) had at least one previous penetrating keratoplasty (mean graft size, 9.2 ± 1.6 mm). The mean pre-surgery BCVA was 1.96 ± 0.23 logMAR. With a mean follow-up period of 20.2 ± 13.4 months, the mean BCVA was 1.57 ± 0.57 logMAR at last follow-up. Overall, 12 grafts (35%) remained clear until the last follow-up, and in 23 grafts (65%), the primary disease recurred, or corneal decompensation developed. Up to the last follow-up, 6 eyes (17%) had to be enucleated.
In complex cases of infectious keratitis requiring a LDPKP to remove the complete pathology and preserve eye integrity, the visual outcomes are generally expected to be poor, not only because of the well-known risks of LDPKP but also because of the consequences of the infectious disease itself. This knowledge is important for adequate counselling of the patient preoperatively.
报告在萨尔兰大学医学中心眼科进行的直径大于 8.5mm 的穿透性角膜移植术在严重角膜疾病中的适应证和结果。
回顾性(6 年)、描述性和观察性研究。
2010 年 3 月至 2016 年 12 月期间,对 27 例(平均年龄 62±22 岁)患者的 35 例大直径穿透性角膜移植术(LDPKP)进行了回顾性分析。记录手术适应证、既往角膜移植次数、术前最佳矫正视力(BCVA)、眼内压、移植物状态以及末次随访时的 BCVA。
感染性角膜炎占适应证的 83%(其中 45%为真菌性)。平均角膜移植直径为 10.8±1.7(最小 8.75,最大 15.0)mm。23 只眼(65%绝对)至少有一次穿透性角膜移植术(平均移植物大小为 9.2±1.6mm)。术前 BCVA 平均为 1.96±0.23logMAR。平均随访 20.2±13.4 个月后,末次随访时平均 BCVA 为 1.57±0.57logMAR。总的来说,12 个移植物(35%)在末次随访时仍保持透明,23 个移植物(65%)中,原发疾病复发或角膜失代偿。截至最后一次随访,有 6 只眼(17%)需要眼球摘除。
在需要 LDPKP 切除全部病变并保留眼球完整性的复杂感染性角膜炎病例中,视力结果通常预计较差,这不仅是因为 LDPKP 本身的风险,还因为感染性疾病本身的后果。这一认识对于术前对患者进行适当的咨询非常重要。